missing translation for 'onlineSavingsMsg'
Learn More
Learn More
C17orf37 Monoclonal Antibody (OTI1D7), TrueMAB™, OriGene
Description
During the past decade, the role of the ERBB2(neu/HER2) oncogene as an important predictor of patient outcome and response to various therapies in breast cancer has been clearly established. The C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer. Identification of shared tumor-specific targets is useful in developing broadly applicable therapies. The C35 gene is located on chromosome 17q12, 505nucleotides from the 3′ end of the ERBB2oncogene, the antigenic target for trastuzumab(Herceptin) therapy. The chromosomal arrangement of the genes encoding C35 andERBB2 is tail to tail. The ORF 37 open reading frame encodes a 12-kDa protein of unknown function.
Specifications
Specifications
| Antigen | C17orf37 |
| Applications | Western Blot |
| Classification | Monoclonal |
| Clone | OTI1D7 |
| Concentration | 0.81 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 1% BSA, 50% glycerol and 0.02% sodium azide |
| Gene | MIEN1 |
| Gene Accession No. | Q9BRT3 |
| Gene Alias | C17orf37, C35, ORB3, RDX12, XTP4 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?